img

Global Fostamatinib Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Fostamatinib Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Fostamatinib report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Fostamatinib market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Idiopathic (Immune) Thrombocytopenic Purpura and Waldenström's Macroglobulinemia are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Fostamatinib industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Fostamatinib key manufacturers include Rigel Pharmaceuticals, Inc, Kissei Pharmaceutical Co., Ltd, Grifols, JW Pharmaceutical Corporation, Medison Pharma Canada and AstraZeneca, etc. Rigel Pharmaceuticals, Inc, Kissei Pharmaceutical Co., Ltd, Grifols are top 3 players and held % sales share in total in 2022.
Fostamatinib can be divided into Tavalisse and Tavlesse, etc. Tavalisse is the mainstream product in the market, accounting for % sales share globally in 2022.
Fostamatinib is widely used in various fields, such as Idiopathic (Immune) Thrombocytopenic Purpura, Waldenström's Macroglobulinemia, Autoimmune Haemolytic Anaemia and Other, etc. Idiopathic (Immune) Thrombocytopenic Purpura provides greatest supports to the Fostamatinib industry development. In 2022, global % sales of Fostamatinib went into Idiopathic (Immune) Thrombocytopenic Purpura filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Fostamatinib market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Rigel Pharmaceuticals, Inc
Kissei Pharmaceutical Co., Ltd
Grifols
JW Pharmaceutical Corporation
Medison Pharma Canada
AstraZeneca
Segment by Type
Tavalisse
Tavlesse

Segment by Application


Idiopathic (Immune) Thrombocytopenic Purpura
Waldenström's Macroglobulinemia
Autoimmune Haemolytic Anaemia
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Fostamatinib market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Fostamatinib, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Fostamatinib industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Fostamatinib in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Fostamatinib introduction, etc. Fostamatinib Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Fostamatinib market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Fostamatinib Market Overview
1.1 Fostamatinib Product Overview
1.2 Fostamatinib Market Segment by Type
1.2.1 Tavalisse
1.2.2 Tavlesse
1.3 Global Fostamatinib Market Size by Type
1.3.1 Global Fostamatinib Market Size Overview by Type (2024-2034)
1.3.2 Global Fostamatinib Historic Market Size Review by Type (2024-2024)
1.3.3 Global Fostamatinib Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Fostamatinib Sales Breakdown by Type (2024-2024)
1.4.2 Europe Fostamatinib Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Fostamatinib Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Fostamatinib Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Fostamatinib Sales Breakdown by Type (2024-2024)
2 Global Fostamatinib Market Competition by Company
2.1 Global Top Players by Fostamatinib Sales (2024-2024)
2.2 Global Top Players by Fostamatinib Revenue (2024-2024)
2.3 Global Top Players by Fostamatinib Price (2024-2024)
2.4 Global Top Manufacturers Fostamatinib Manufacturing Base Distribution, Sales Area, Product Type
2.5 Fostamatinib Market Competitive Situation and Trends
2.5.1 Fostamatinib Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Fostamatinib Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Fostamatinib as of 2022)
2.7 Date of Key Manufacturers Enter into Fostamatinib Market
2.8 Key Manufacturers Fostamatinib Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Fostamatinib Status and Outlook by Region
3.1 Global Fostamatinib Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Fostamatinib Historic Market Size by Region
3.2.1 Global Fostamatinib Sales in Volume by Region (2024-2024)
3.2.2 Global Fostamatinib Sales in Value by Region (2024-2024)
3.2.3 Global Fostamatinib Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Fostamatinib Forecasted Market Size by Region
3.3.1 Global Fostamatinib Sales in Volume by Region (2024-2034)
3.3.2 Global Fostamatinib Sales in Value by Region (2024-2034)
3.3.3 Global Fostamatinib Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Fostamatinib by Application
4.1 Fostamatinib Market Segment by Application
4.1.1 Idiopathic (Immune) Thrombocytopenic Purpura
4.1.2 Waldenström's Macroglobulinemia
4.1.3 Autoimmune Haemolytic Anaemia
4.1.4 Other
4.2 Global Fostamatinib Market Size by Application
4.2.1 Global Fostamatinib Market Size Overview by Application (2024-2034)
4.2.2 Global Fostamatinib Historic Market Size Review by Application (2024-2024)
4.2.3 Global Fostamatinib Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Fostamatinib Sales Breakdown by Application (2024-2024)
4.3.2 Europe Fostamatinib Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Fostamatinib Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Fostamatinib Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Fostamatinib Sales Breakdown by Application (2024-2024)
5 North America Fostamatinib by Country
5.1 North America Fostamatinib Historic Market Size by Country
5.1.1 North America Fostamatinib Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Fostamatinib Sales in Volume by Country (2024-2024)
5.1.3 North America Fostamatinib Sales in Value by Country (2024-2024)
5.2 North America Fostamatinib Forecasted Market Size by Country
5.2.1 North America Fostamatinib Sales in Volume by Country (2024-2034)
5.2.2 North America Fostamatinib Sales in Value by Country (2024-2034)
6 Europe Fostamatinib by Country
6.1 Europe Fostamatinib Historic Market Size by Country
6.1.1 Europe Fostamatinib Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Fostamatinib Sales in Volume by Country (2024-2024)
6.1.3 Europe Fostamatinib Sales in Value by Country (2024-2024)
6.2 Europe Fostamatinib Forecasted Market Size by Country
6.2.1 Europe Fostamatinib Sales in Volume by Country (2024-2034)
6.2.2 Europe Fostamatinib Sales in Value by Country (2024-2034)
7 Asia-Pacific Fostamatinib by Region
7.1 Asia-Pacific Fostamatinib Historic Market Size by Region
7.1.1 Asia-Pacific Fostamatinib Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Fostamatinib Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Fostamatinib Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Fostamatinib Forecasted Market Size by Region
7.2.1 Asia-Pacific Fostamatinib Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Fostamatinib Sales in Value by Region (2024-2034)
8 Latin America Fostamatinib by Country
8.1 Latin America Fostamatinib Historic Market Size by Country
8.1.1 Latin America Fostamatinib Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Fostamatinib Sales in Volume by Country (2024-2024)
8.1.3 Latin America Fostamatinib Sales in Value by Country (2024-2024)
8.2 Latin America Fostamatinib Forecasted Market Size by Country
8.2.1 Latin America Fostamatinib Sales in Volume by Country (2024-2034)
8.2.2 Latin America Fostamatinib Sales in Value by Country (2024-2034)
9 Middle East and Africa Fostamatinib by Country
9.1 Middle East and Africa Fostamatinib Historic Market Size by Country
9.1.1 Middle East and Africa Fostamatinib Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Fostamatinib Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Fostamatinib Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Fostamatinib Forecasted Market Size by Country
9.2.1 Middle East and Africa Fostamatinib Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Fostamatinib Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Rigel Pharmaceuticals, Inc
10.1.1 Rigel Pharmaceuticals, Inc Company Information
10.1.2 Rigel Pharmaceuticals, Inc Introduction and Business Overview
10.1.3 Rigel Pharmaceuticals, Inc Fostamatinib Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Rigel Pharmaceuticals, Inc Fostamatinib Products Offered
10.1.5 Rigel Pharmaceuticals, Inc Recent Development
10.2 Kissei Pharmaceutical Co., Ltd
10.2.1 Kissei Pharmaceutical Co., Ltd Company Information
10.2.2 Kissei Pharmaceutical Co., Ltd Introduction and Business Overview
10.2.3 Kissei Pharmaceutical Co., Ltd Fostamatinib Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Kissei Pharmaceutical Co., Ltd Fostamatinib Products Offered
10.2.5 Kissei Pharmaceutical Co., Ltd Recent Development
10.3 Grifols
10.3.1 Grifols Company Information
10.3.2 Grifols Introduction and Business Overview
10.3.3 Grifols Fostamatinib Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Grifols Fostamatinib Products Offered
10.3.5 Grifols Recent Development
10.4 JW Pharmaceutical Corporation
10.4.1 JW Pharmaceutical Corporation Company Information
10.4.2 JW Pharmaceutical Corporation Introduction and Business Overview
10.4.3 JW Pharmaceutical Corporation Fostamatinib Sales, Revenue and Gross Margin (2024-2024)
10.4.4 JW Pharmaceutical Corporation Fostamatinib Products Offered
10.4.5 JW Pharmaceutical Corporation Recent Development
10.5 Medison Pharma Canada
10.5.1 Medison Pharma Canada Company Information
10.5.2 Medison Pharma Canada Introduction and Business Overview
10.5.3 Medison Pharma Canada Fostamatinib Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Medison Pharma Canada Fostamatinib Products Offered
10.5.5 Medison Pharma Canada Recent Development
10.6 AstraZeneca
10.6.1 AstraZeneca Company Information
10.6.2 AstraZeneca Introduction and Business Overview
10.6.3 AstraZeneca Fostamatinib Sales, Revenue and Gross Margin (2024-2024)
10.6.4 AstraZeneca Fostamatinib Products Offered
10.6.5 AstraZeneca Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Fostamatinib Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Fostamatinib Industrial Chain Analysis
11.4 Fostamatinib Market Dynamics
11.4.1 Fostamatinib Industry Trends
11.4.2 Fostamatinib Market Drivers
11.4.3 Fostamatinib Market Challenges
11.4.4 Fostamatinib Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Fostamatinib Distributors
12.3 Fostamatinib Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Tavalisse
Table 2. Major Company of Tavlesse
Table 3. Global Fostamatinib Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Fostamatinib Sales by Type (2024-2024) & (K Bottles)
Table 5. Global Fostamatinib Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Fostamatinib Sales by Type (2024-2024) & (US& Million)
Table 7. Global Fostamatinib Market Share in Value by Type (2024-2024)
Table 8. Global Fostamatinib Price by Type (2024-2024) & (US$/Bottle)
Table 9. Global Fostamatinib Sales by Type (2024-2034) & (K Bottles)
Table 10. Global Fostamatinib Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Fostamatinib Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Fostamatinib Sales Market Share in Value by Type (2024-2034)
Table 13. Global Fostamatinib Price by Type (2024-2034) & (US$/Bottle)
Table 14. North America Fostamatinib Sales by Type (2024-2024) & (K Bottles)
Table 15. North America Fostamatinib Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Fostamatinib Sales (K Bottles) by Type (2024-2024)
Table 17. Europe Fostamatinib Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Fostamatinib Sales (K Bottles) by Type (2024-2024)
Table 19. Asia-Pacific Fostamatinib Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Fostamatinib Sales (K Bottles) by Type (2024-2024)
Table 21. Latin America Fostamatinib Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Fostamatinib Sales (K Bottles) by Type (2024-2024)
Table 23. Middle East and Africa Fostamatinib Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Fostamatinib Sales by Company (2024-2024) & (K Bottles)
Table 25. Global Fostamatinib Sales Share by Company (2024-2024)
Table 26. Global Fostamatinib Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Fostamatinib Revenue Share by Company (2024-2024)
Table 28. Global Market Fostamatinib Price by Company (2024-2024) & (US$/Bottle)
Table 29. Global Fostamatinib Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Fostamatinib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Fostamatinib as of 2022)
Table 32. Date of Key Manufacturers Enter into Fostamatinib Market
Table 33. Key Manufacturers Fostamatinib Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Fostamatinib Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Fostamatinib Sales by Region (2024-2024) & (K Bottles)
Table 37. Global Fostamatinib Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Fostamatinib Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Fostamatinib Sales Market Share in Value by Region (2024-2024)
Table 40. Global Fostamatinib Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2024-2024)
Table 41. Global Fostamatinib Sales by Region (2024-2034) & (K Bottles)
Table 42. Global Fostamatinib Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Fostamatinib Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Fostamatinib Sales Market Share in Value by Region (2024-2034)
Table 45. Global Fostamatinib Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2024-2034)
Table 46. Global Fostamatinib Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Fostamatinib Sales by Application (2024-2024) & (K Bottles)
Table 48. Global Fostamatinib Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Fostamatinib Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Fostamatinib Sales Market Share in Value by Application (2024-2024)
Table 51. Global Fostamatinib Price by Application (2024-2024) & (US$/Bottle)
Table 52. Global Fostamatinib Sales by Application (2024-2034) & (K Bottles)
Table 53. Global Fostamatinib Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Fostamatinib Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Fostamatinib Sales Market Share in Value by Application (2024-2034)
Table 56. Global Fostamatinib Price by Application (2024-2034) & (US$/Bottle)
Table 57. North America Fostamatinib Sales by Application (2024-2024) (K Bottles)
Table 58. North America Fostamatinib Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Fostamatinib Sales by Application (2024-2024) (K Bottles)
Table 60. Europe Fostamatinib Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Fostamatinib Sales by Application (2024-2024) (K Bottles)
Table 62. Asia-Pacific Fostamatinib Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Fostamatinib Sales by Application (2024-2024) (K Bottles)
Table 64. Latin America Fostamatinib Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Fostamatinib Sales by Application (2024-2024) (K Bottles)
Table 66. Middle East and Africa Fostamatinib Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Fostamatinib Sales by Country (2024-2024) & (K Bottles)
Table 68. North America Fostamatinib Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Fostamatinib Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Fostamatinib Sales Market Share in Value by Country (2024-2024)
Table 71. North America Fostamatinib Sales by Country (2024-2034) & (K Bottles)
Table 72. North America Fostamatinib Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Fostamatinib Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Fostamatinib Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Fostamatinib Sales by Country (2024-2024) & (K Bottles)
Table 76. Europe Fostamatinib Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Fostamatinib Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Fostamatinib Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Fostamatinib Sales by Country (2024-2034) & (K Bottles)
Table 80. Europe Fostamatinib Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Fostamatinib Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Fostamatinib Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Fostamatinib Sales by Region (2024-2024) & (K Bottles)
Table 84. Asia-Pacific Fostamatinib Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Fostamatinib Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Fostamatinib Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Fostamatinib Sales by Region (2024-2034) & (K Bottles)
Table 88. Asia-Pacific Fostamatinib Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Fostamatinib Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Fostamatinib Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Fostamatinib Sales by Country (2024-2024) & (K Bottles)
Table 92. Latin America Fostamatinib Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Fostamatinib Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Fostamatinib Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Fostamatinib Sales by Country (2024-2034) & (K Bottles)
Table 96. Latin America Fostamatinib Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Fostamatinib Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Fostamatinib Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Fostamatinib Sales by Country (2024-2024) & (K Bottles)
Table 100. Middle East and Africa Fostamatinib Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Fostamatinib Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Fostamatinib Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Fostamatinib Sales by Country (2024-2034) & (K Bottles)
Table 104. Middle East and Africa Fostamatinib Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Fostamatinib Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Fostamatinib Sales Market Share in Value by Country (2024-2034)
Table 107. Rigel Pharmaceuticals, Inc Company Information
Table 108. Rigel Pharmaceuticals, Inc Introduction and Business Overview
Table 109. Rigel Pharmaceuticals, Inc Fostamatinib Sales (K Bottles), Revenue (Million USD), Price (US$/Bottle) and Gross Margin (2024-2024)
Table 110. Rigel Pharmaceuticals, Inc Fostamatinib Product
Table 111. Rigel Pharmaceuticals, Inc Recent Development
Table 112. Kissei Pharmaceutical Co., Ltd Company Information
Table 113. Kissei Pharmaceutical Co., Ltd Introduction and Business Overview
Table 114. Kissei Pharmaceutical Co., Ltd Fostamatinib Sales (K Bottles), Revenue (Million USD), Price (US$/Bottle) and Gross Margin (2024-2024)
Table 115. Kissei Pharmaceutical Co., Ltd Fostamatinib Product
Table 116. Kissei Pharmaceutical Co., Ltd Recent Development
Table 117. Grifols Company Information
Table 118. Grifols Introduction and Business Overview
Table 119. Grifols Fostamatinib Sales (K Bottles), Revenue (Million USD), Price (US$/Bottle) and Gross Margin (2024-2024)
Table 120. Grifols Fostamatinib Product
Table 121. Grifols Recent Development
Table 122. JW Pharmaceutical Corporation Company Information
Table 123. JW Pharmaceutical Corporation Introduction and Business Overview
Table 124. JW Pharmaceutical Corporation Fostamatinib Sales (K Bottles), Revenue (Million USD), Price (US$/Bottle) and Gross Margin (2024-2024)
Table 125. JW Pharmaceutical Corporation Fostamatinib Product
Table 126. JW Pharmaceutical Corporation Recent Development
Table 127. Medison Pharma Canada Company Information
Table 128. Medison Pharma Canada Introduction and Business Overview
Table 129. Medison Pharma Canada Fostamatinib Sales (K Bottles), Revenue (Million USD), Price (US$/Bottle) and Gross Margin (2024-2024)
Table 130. Medison Pharma Canada Fostamatinib Product
Table 131. Medison Pharma Canada Recent Development
Table 132. AstraZeneca Company Information
Table 133. AstraZeneca Introduction and Business Overview
Table 134. AstraZeneca Fostamatinib Sales (K Bottles), Revenue (Million USD), Price (US$/Bottle) and Gross Margin (2024-2024)
Table 135. AstraZeneca Fostamatinib Product
Table 136. AstraZeneca Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Fostamatinib Market Trends
Table 140. Fostamatinib Market Drivers
Table 141. Fostamatinib Market Challenges
Table 142. Fostamatinib Market Restraints
Table 143. Fostamatinib Distributors List
Table 144. Fostamatinib Downstream Customers
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Fostamatinib Product Picture
Figure 2. Global Fostamatinib Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Fostamatinib Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Fostamatinib Sales Status and Outlook (2024-2034) & (K Bottles)
Figure 5. Product Picture of Tavalisse
Figure 6. Global Tavalisse Sales YoY Growth (2024-2034) & (K Bottles)
Figure 7. Product Picture of Tavlesse
Figure 8. Global Tavlesse Sales YoY Growth (2024-2034) & (K Bottles)
Figure 9. Global Fostamatinib Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Fostamatinib Sales Market Share by Type in 2022 & 2034
Figure 11. North America Fostamatinib Sales Market Share in Volume by Type in 2022
Figure 12. North America Fostamatinib Sales Market Share in Value by Type in 2022
Figure 13. Europe Fostamatinib Sales Market Share in Volume by Type in 2022
Figure 14. Europe Fostamatinib Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Fostamatinib Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Fostamatinib Sales Market Share in Value by Type in 2022
Figure 17. Latin America Fostamatinib Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Fostamatinib Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Fostamatinib Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Fostamatinib Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Fostamatinib Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Fostamatinib Revenue in 2022
Figure 23. Fostamatinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Idiopathic (Immune) Thrombocytopenic Purpura
Figure 25. Global Idiopathic (Immune) Thrombocytopenic Purpura Sales YoY Growth (2024-2034) & (K Bottles)
Figure 26. Product Picture of Waldenström's Macroglobulinemia
Figure 27. Global Waldenström's Macroglobulinemia Sales YoY Growth (2024-2034) & (K Bottles)
Figure 28. Product Picture of Autoimmune Haemolytic Anaemia
Figure 29. Global Autoimmune Haemolytic Anaemia Sales YoY Growth (2024-2034) & (K Bottles)
Figure 30. Product Picture of Other
Figure 31. Global Other Sales YoY Growth (2024-2034) & (K Bottles)
Figure 32. Global Fostamatinib Sales by Application (2024-2034) & (US$ Million)
Figure 33. Global Fostamatinib Sales Market Share by Application in 2022 & 2034
Figure 34. North America Fostamatinib Sales Market Share in Volume by Application in 2022
Figure 35. North America Fostamatinib Sales Market Share in Value by Application in 2022
Figure 36. Europe Fostamatinib Sales Market Share in Volume by Application in 2022
Figure 37. Europe Fostamatinib Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Fostamatinib Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Fostamatinib Sales Market Share in Value by Application in 2022
Figure 40. Latin America Fostamatinib Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Fostamatinib Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Fostamatinib Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Fostamatinib Manufacturing Cost Structure
Figure 45. Fostamatinib Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed